NO20032356D0 - Fremgangsmåte ved folding av kjemisk syntetiserte polypeptider - Google Patents

Fremgangsmåte ved folding av kjemisk syntetiserte polypeptider

Info

Publication number
NO20032356D0
NO20032356D0 NO20032356A NO20032356A NO20032356D0 NO 20032356 D0 NO20032356 D0 NO 20032356D0 NO 20032356 A NO20032356 A NO 20032356A NO 20032356 A NO20032356 A NO 20032356A NO 20032356 D0 NO20032356 D0 NO 20032356D0
Authority
NO
Norway
Prior art keywords
chemically synthesized
folding
synthesized polypeptides
cysteine
reducing agent
Prior art date
Application number
NO20032356A
Other languages
English (en)
Norwegian (no)
Other versions
NO20032356L (no
Inventor
Antonio Verdini
Giampietro Corradin
Mario Roggero
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Publication of NO20032356L publication Critical patent/NO20032356L/no
Publication of NO20032356D0 publication Critical patent/NO20032356D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20032356A 2000-11-27 2003-05-26 Fremgangsmåte ved folding av kjemisk syntetiserte polypeptider NO20032356D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204207 2000-11-27
PCT/EP2001/014163 WO2002050099A2 (en) 2000-11-27 2001-11-27 Process for folding chemically synthesized polypeptides

Publications (2)

Publication Number Publication Date
NO20032356L NO20032356L (no) 2003-05-26
NO20032356D0 true NO20032356D0 (no) 2003-05-26

Family

ID=8172340

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032356A NO20032356D0 (no) 2000-11-27 2003-05-26 Fremgangsmåte ved folding av kjemisk syntetiserte polypeptider

Country Status (22)

Country Link
US (2) US20020082384A1 (pt)
EP (2) EP1337549B1 (pt)
JP (1) JP2004516300A (pt)
KR (1) KR20030081315A (pt)
CN (2) CN1249078C (pt)
AT (1) ATE322501T1 (pt)
AU (2) AU2002229603B2 (pt)
BR (1) BR0113091A (pt)
CA (1) CA2416054A1 (pt)
CU (1) CU23034A3 (pt)
DE (1) DE60118598T2 (pt)
DK (1) DK1337549T3 (pt)
ES (1) ES2261509T4 (pt)
HU (1) HUP0302395A3 (pt)
IL (1) IL155506A0 (pt)
MX (1) MXPA03003576A (pt)
NO (1) NO20032356D0 (pt)
NZ (1) NZ523679A (pt)
PL (1) PL364932A1 (pt)
RU (1) RU2275377C2 (pt)
WO (1) WO2002050099A2 (pt)
ZA (1) ZA200300642B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091310B2 (en) * 2002-09-13 2006-08-15 Chemokine Therapeutics Corporation Chemokine analogs for the treatment of human disease
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
JP4674702B2 (ja) 2003-04-09 2011-04-20 バイオジェネリクス エージー グリコペギレ−ション法およびその方法により生成されたタンパク質／ペプチド
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
BRPI0518390A2 (pt) * 2004-10-26 2008-11-18 Lonza Ag mÉtodo de sÍntese de peptÍdeo, e respectivo peptÍdeo
HUE026826T2 (en) 2004-10-29 2016-07-28 Ratiopharm Gmbh Modeling and glycopegylation of fibroblast growth factor (FGF)
JP4951527B2 (ja) 2005-01-10 2012-06-13 バイオジェネリックス アーゲー 糖ｐｅｇ化顆粒球コロニー刺激因子
US20070154992A1 (en) 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
JP5335422B2 (ja) * 2005-06-17 2013-11-06 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 少なくとも１つの非天然のシステインを含んでいる操作されたタンパク質の選択的な還元および誘導体化
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
WO2007056191A2 (en) 2005-11-03 2007-05-18 Neose Technologies, Inc. Nucleotide sugar purification using membranes
EP1966231A1 (de) * 2005-12-23 2008-09-10 AplaGen GmbH Verfahren zur ausbildung von disulfidbrücken
CA2651070A1 (en) * 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
JP2010505874A (ja) 2006-10-03 2010-02-25 ノヴォ ノルディスク アー／エス ポリペプチドコンジュゲートの精製方法
EP2125863A1 (de) * 2006-12-23 2009-12-02 AplaGen GmbH Verfahren zur ausbildung von disulfidbrücken
ES2406267T3 (es) 2007-04-03 2013-06-06 Biogenerix Ag Métodos de tratamiento usando G-CSF glicopegilado
MX2009013259A (es) 2007-06-12 2010-01-25 Novo Nordisk As Proceso mejorado para la produccion de azucares de nucleotidos.
AU2009219232B2 (en) 2008-02-27 2014-02-27 Novo Nordisk A/S Conjugated Factor VIII molecules
CN104844693B (zh) * 2015-06-10 2018-08-03 成都圣诺生物科技股份有限公司 一种合成利那洛肽的方法
WO2019149918A1 (en) 2018-02-02 2019-08-08 Novo Nordisk A/S Drug injection device with deflectable transducer
CN111100188A (zh) * 2018-10-25 2020-05-05 成都医学院 一种制备蜘蛛抗菌肽的方法
CN109593119A (zh) * 2019-01-27 2019-04-09 上海丽珠制药有限公司 一种[2-d-组氨酸]-醋酸亮丙瑞林的制备方法
JP7453745B2 (ja) * 2019-03-28 2024-03-21 株式会社ヤクルト本社 毒性タンパク質の活性を阻害するペプチドのスクリーニング方法及び毒性タンパク質の製造方法
CN110845595A (zh) * 2019-11-14 2020-02-28 连云港职业技术学院 一种固相合成5-tmara标记的铁调素-25的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
DE3236849A1 (de) * 1982-10-05 1984-04-05 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue thiohydrazin-1,2-dicarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
CN1105029A (zh) * 1993-05-24 1995-07-12 花王株式会社 制备溶解蛋白质的方法
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
DE4431317A1 (de) * 1994-09-02 1996-03-07 Biotechnolog Forschung Gmbh Schutz- bzw. Ankergruppen und deren Verwendung

Also Published As

Publication number Publication date
MXPA03003576A (es) 2003-10-14
ES2261509T3 (es) 2006-11-16
EP1337549B1 (en) 2006-04-05
AU2960302A (en) 2002-07-01
NO20032356L (no) 2003-05-26
NZ523679A (en) 2005-10-28
CN1249078C (zh) 2006-04-05
ES2261509T4 (es) 2008-02-16
DK1337549T3 (da) 2006-07-31
HUP0302395A3 (en) 2007-05-02
CU23034A3 (es) 2005-03-22
AU2002229603B2 (en) 2007-11-08
EP1337549A2 (en) 2003-08-27
CN1830999A (zh) 2006-09-13
KR20030081315A (ko) 2003-10-17
DE60118598D1 (de) 2006-05-18
DE60118598T2 (de) 2007-02-15
HUP0302395A2 (hu) 2003-10-28
US20020082384A1 (en) 2002-06-27
CA2416054A1 (en) 2002-06-27
ZA200300642B (en) 2004-07-16
JP2004516300A (ja) 2004-06-03
ATE322501T1 (de) 2006-04-15
PL364932A1 (en) 2004-12-27
BR0113091A (pt) 2003-07-08
RU2275377C2 (ru) 2006-04-27
CN1449406A (zh) 2003-10-15
US20050239162A1 (en) 2005-10-27
WO2002050099A2 (en) 2002-06-27
WO2002050099A3 (en) 2002-09-19
IL155506A0 (en) 2003-11-23
EP1679318A1 (en) 2006-07-12

Similar Documents

Publication Publication Date Title
NO20032356D0 (no) Fremgangsmåte ved folding av kjemisk syntetiserte polypeptider
ATE293159T1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
ES2062812T3 (es) Composicion detergente enzimatica y metodo para estabilizar enzimas.
WO2002018583A3 (en) Modified polypeptides stabilized in a desired conformation and methods for producing same
EP1350846A4 (en) C-TERMINAL MODIFIED PROTEIN AND METHOD FOR THE PRODUCTION THEREOF, IN THE PREPARATION OF C-TERMINAL MODIFIED PROTEIN TO BE USED, AND TRANSLATION TEMPLATE AND METHOD FOR DETECTING PROTEIN CHANGING EFFECT USING THE C-TERMINAL MODIFIED PROTEIN
PT94633A (pt) Metodo para a desnaturacao oxidante de analitos de proteina
BR9709569B1 (pt) processo para ativação de proteìna desnaturada.
BR9911891A (pt) Proteases fundidas com variantes de inibidor de subtilisina de streptomyces
AU583723B2 (en) Process for renaturing of proteins
ATE331032T1 (de) Glutamine: fructose-6-phosphat amidotransferase (gfat), ihre herstellung und verwendung
ATE113986T1 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
ATE364607T1 (de) Verfahren zur produktion von 2,6- dihalogenopurinen
IL162133A0 (en) Method of increasing protein expression, proteins and polynucleotides
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods
NO985902D0 (no) FremgangsmÕte ved ekstrahering og rensning av rekombinant, ikke-lipidert Osp-protein
EP1385979A4 (en) METHOD FOR IMPROVING THE TRANSLATION AND EXPRESSION OF RECOMBINANT PROTEINS
ATE473241T1 (de) Neue hämpeptide
KR950032634A (ko) 스트렙토마이세스 써모니트리피컨스 아미노펩티다제를 이용한 천연형 재조합 단백질의 제조방법